Kamada (KMDA) Shares Outstanding (2012 - 2026)
Kamada's (KMDA) quarterly Shares Outstanding (Entity) came in at $15.1 million in Q1 2026, little changed YoY from $15.1 million in Q1 2025, and down 73.86% on a QoQ basis from $57.7 million in Q4 2025.
Kamada (KMDA) Shares Outstanding (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Shares Outstanding (Entity) data on file, last reported at $15.1 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.03% year-over-year to $15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.1 million (changed 0.03% YoY) and the FY2025 annual result came in at $57.7 million, changed 0.31% from the prior year.
- Shares Outstanding (Entity) slipped to $15.1 million in Q1 2026, from $57.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $57.7 million in Q4 2025 to a low of $6.7 million in Q3 2024.
- A 5-year average of $23.9 million and a median of $15.1 million in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2025 — Shares Outstanding (Entity) jumped 126.11% — and 2026, when it increased 0.03%.
- Tracing KMDA's Shares Outstanding (Entity) over 5 years: stood at $44.8 million in 2022, then grew by 28.21% to $57.5 million in 2023, then rose by 0.04% to $57.5 million in 2024, then gained by 0.31% to $57.7 million in 2025, then slumped by 73.86% to $15.1 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $15.1 million (Q1 2026), $57.7 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn | 57.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 57.65 Mn |
| Mar 31, 2026 | 57.65 Mn |
| Dec 31, 2025 | 57.65 Mn |
| Sep 30, 2025 | 57.49 Mn |
| Jun 30, 2025 | 57.49 Mn |
| Mar 31, 2025 | 57.49 Mn |
| Dec 31, 2024 | 57.49 Mn |
| Sep 30, 2024 | 6.67 Mn |
| Jun 30, 2024 | 48.83 Mn |
| Mar 31, 2024 | 48.83 Mn |
| Dec 31, 2023 | 48.83 Mn |
| Sep 30, 2023 | 44.82 Mn |
| Jun 30, 2023 | 44.82 Mn |
| Mar 31, 2023 | 44.82 Mn |
| Dec 31, 2022 | 44.82 Mn |
| Sep 30, 2022 | 44.77 Mn |
| Jun 30, 2022 | 44.77 Mn |
| Mar 31, 2022 | 44.77 Mn |
| Dec 31, 2021 | 44.77 Mn |
| Sep 30, 2021 | 44.14 Mn |